Investing.com - William Blair reiterated an Outperform rating on GoDaddy Inc (NYSE:GDDY). The firm noted GoDaddy trades at 7 times its 2027 free cash flow estimate. This valuation appears attractive ...

indie Semiconductor, Inc. (NASDAQ:INDI) is included in our list of the 11 most oversold semiconductor stocks to buy now. Positive analyst sentiment continues to surround indie Semiconductor, Inc.

Changes in Google’s AI-powered search experiences are beginning to alter the way users interact with sources inside search results, prompting new discussions about how visibility and click behavior ...

A conservative lawyer issued a blistering takedown of President Donald Trump’s attempt to prosecute six Democratic members of Congress. Andrew McCarthy, a Fox News legal analyst and National Review ...

Bitcoin ETFs may be sitting on their “biggest losses” since launching in January 2024, but there is a silver lining, according to an ETF analyst. US-based spot Bitcoin exchange-traded fund (ETF) ...

Jefferies strategist Christopher Wood has dropped Bitcoin from his Greed & Fear portfolio, citing quantum computing as a potential existential threat to its cryptography. Christopher Wood, global head ...

Alex Thorn, head of firmwide research at Galaxy Digital, has shared a fresh warning about the CLARITY bill. If the draft of the bill currently circulating in the Senate Banking Committee becomes a law ...

NEW ORLEANS (WVUE) - The New Orleans Inspector General Office released a report Wednesday (1/8) finding the city’s controversial traffic camera program owes drivers thousands in overpaid tickets. At ...

Alphabet's artificial intelligence capabilities will lead the stock to further gains, according to Cantor Fitzgerald. The firm upgraded the "Magnificent Seven" titan to overweight from neutral.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Progress is definitely on its ...

Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene Further improves 2026 and 2027 expected GAAP ...